Baxter International Inc. Profile Avatar - Palmy Investing

Baxter International Inc.

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infus…

Medical - Instruments & Supplies
US, Deerfield [HQ]
Financials

Analysts

Reported
Past Estimate Consensus
Future Estimate Consensus
EPS Revenue EBITDA EBIT SGA
FY EPS Revenue [mil.] Profit [mil.] EBITDA [mil.] EBIT [mil.] Expenses · SGA [mil.]
E E E E E E
2014 3.7000 4.760 15,259 10,289 2,012 2,407 3,500 4,023 2,668 2,713 3,681 5,808
2015 4.6100 1.258 16,671 9,907 2,497 821 3,589 1,770 2,707 1,007 4,029 2,908
2016 1.7800 1.907 9,968 10,170 968 3,912 554 4,635 449 595 3,094 2,236
2017 9.0900 2.431 10,163 10,557 4,965 642 5,020 1,855 724 1,133 2,739 2,337
2018 1.1100 3.001 10,561 11,082 717 1,476 2,043 2,331 1,258 1,452 2,599 2,336
2019 3.0400 3.414 11,127 11,362 1,624 1,727 1,738 1,324 1,599 446 2,617 2,830
2020 1.9700 3.056 11,362 11,582 1,001 1,021 1,765 2,112 876 1,506 3,290 2,366
2021 2.1700 3.597 11,673 12,570 1,102 1,168 1,426 2,341 1,616 1,562 2,469 2,653
2022 2.5600 3.559 12,784 14,997 1,284 1,023 1,669 2,574 1,710 1,409 2,867 3,517
2023 -4.8000 2.587 15,113 14,740 -2,421 -157 854 2,831 869 1,550 3,887 3,869
2024 -0.4500 2.947 14,813 15,225 2,656 1,491 1,751 1,774 412 598 3,896 3,792
2025 - 3.018 - 14,789 - 1,536 - 1,723 - 581 - 3,684
2026 - 1.F12X/td> - 1.F12X/td> - 1.F12X/td> - 1.F121/td> - 1.F121 - 1.F121
2027 - 0.F13X/td> - 0.F13X/td> - 0.F13X/td> - 0.F131/td> - 0.F131 - 0.F131
End of BAX's Analysis
CIK: 10456 CUSIP: 071813109 ISIN: US0718131099 LEI: - UEI: -
Secondary Listings